Taiwan Grene Biotechnology

Taiwan Grene Biotechnology is a regenerative medicine company specializing in the development and application of cell-based therapies and exosome technologies. The company focuses on utilizing mesenchymal stem cells (MSCs) for treating degenerative diseases, such as osteoarthritis, and enhancing tissue repair. In addition to its therapeutic pipeline, Taiwan Grene Biotechnology provides CDMO services for cell processing and develops high-end skincare products derived from its proprietary cell culture technologies. The firm aims to integrate clinical research with industrial manufacturing to advance the field of precision medicine in Asia. Their platform technology facilitates the standardized production of high-purity stem cells for clinical use under Taiwan's regulatory framework.